Anti-adhesive to be tested in breast surgery:
This article was originally published in Clinica
Executive Summary
Gliatech has been told by the FDA that it can start a US pilot trial of its ADCON-L adhesion control gel on women who have undergone breast augmentation surgery. The gel, which is already approved for inhibiting scarring and adhesions following lumbar spine surgery, will be used to try and reduce capsular contraction. This condition, which causes a scar around the breast implant, can lead to further operations, said Cleveland, Ohio-based Gliatech.